Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
about
Deferasirox for managing iron overload in people with myelodysplastic syndromeEvaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusionsDecision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate.Targeting iron metabolism in drug discovery and deliveryQualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.Thalassaemia in children: from quality of care to quality of life.Deferasirox for managing iron overload in people with thalassaemia.Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.Iron chelation therapy in low risk myelodysplastic syndrome.Satisfaction of Nigerian stroke survivors with outpatient physiotherapy care.Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major.Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.Optimizing Communication and Adherence to Iron Chelation Therapy From Diagnosis to Treatment in Patients With Myelodysplastic Syndromes.Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemiaJadenu Substituting Exjade in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles
P2860
Q24193067-C1F05E40-5B53-40A1-80B3-1ECA2E484D5AQ26765306-BF1EBA8A-BA4A-4DB9-905E-84E6363093CBQ30240190-72178741-9F7C-43A2-8B46-677809F05F5DQ33757232-8A164811-E457-4DBB-9466-F0A3AE96D153Q33827300-4EA6DFFD-AF1A-40A3-A213-211595F81701Q38101043-0129FA7A-EEB1-46AD-8C3C-0F84977CD8C4Q38569638-74AF609A-7F04-4465-BF1D-714F4C7C29A9Q38624033-2FF79B73-412D-44D2-8715-61B556A6BBCAQ38662673-B5F507EB-32FA-4C05-A131-B32F71FC8B39Q38903926-7B5307AD-424B-4254-81A2-38F577C02D26Q39149256-0A65337B-2A14-4EFE-805E-539E601DDF93Q39322708-56747850-114B-4C29-868C-C5B3DB62A954Q41562000-77964540-25B3-46AC-BB7B-8DB54B11E978Q45132809-6BB851E5-E361-4A72-AD3D-282400FB93CCQ45340443-E846D11C-DA11-4BB9-BEDF-EEEF1668DF45Q47581898-659F0B60-8AE6-42A2-9474-03DB37E63953Q54963190-E9932DB7-4C0B-4382-B980-9C95023EC010Q54983014-EE998B3D-B2A2-4D54-8A5A-ED0B7CCAE6D1Q56389520-D2B5E1E1-F364-440A-A208-59AD860282C3Q58701135-D980D0FF-9232-4DED-B658-932685E9B107
P2860
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@en
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@nl
type
label
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@en
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@nl
prefLabel
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@en
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@nl
P2093
P2860
P50
P356
P1433
P1476
Health-Related Quality of Life ...... s from the EPIC Clinical Trial
@en
P2093
Adam Gater
Arnold Ganser
Diana Rofail
Donald K Bowden
Jacques Troncy
Linda Abetz-Webb
Marina Economou
P2860
P304
P356
10.1155/2012/297641
P577
2012-08-12T00:00:00Z